Trutino Biosciences
Founded Year
2018Stage
Acquired | AcquiredTotal Raised
$1.5MAbout Trutino Biosciences
Trutino Biosciences operates as a pre-clinical stage biotechnology company. It develops cytokine therapies for optimal retention and targeted activation at the disease site. It enables the therapeutic power of cytokines in immuno-oncology and autoimmune diseases (AD) to trigger cancer-fighting immune cells. The company was founded in 2018 and is based in San Diego, California. In June 2022, Trutino Biosciences was acquired by Boehringer Ingelheim.
Loading...
Loading...
Trutino Biosciences Patents
Trutino Biosciences has filed 2 patents.
The 3 most popular patent topics include:
- immunology
- abandoned drugs
- cancer treatments
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/31/2020 | Immune system, Immunology, Clusters of differentiation, Cancer treatments, Oncology | Application |
Application Date | 1/31/2020 |
|---|---|
Grant Date | |
Title | |
Related Topics | Immune system, Immunology, Clusters of differentiation, Cancer treatments, Oncology |
Status | Application |
Latest Trutino Biosciences News
Jun 16, 2022
Germany-based Boehringer Ingelheim, a leading biopharmaceutical company, has signed an option to acquire Trutino Biosciences (Trutino), a San Diego-based pre-clinical stage biotech company dedicated to the discovery and development of next-generation cytokine therapies to treat immuno-oncology and autoimmune diseases. Under the agreement, Boehringer Ingelheim reserves the right to purchase all shares of Trutino once specified […]
Trutino Biosciences Frequently Asked Questions (FAQ)
When was Trutino Biosciences founded?
Trutino Biosciences was founded in 2018.
Where is Trutino Biosciences's headquarters?
Trutino Biosciences's headquarters is located at 3210 Merryfield Row, San Diego.
What is Trutino Biosciences's latest funding round?
Trutino Biosciences's latest funding round is Acquired.
How much did Trutino Biosciences raise?
Trutino Biosciences raised a total of $1.5M.
Who are the investors of Trutino Biosciences?
Investors of Trutino Biosciences include Boehringer Ingelheim, Creative Destruction Lab, Partners Investment and JLabs.
Loading...
Loading...